drug
carbamazepine ER
Marketedupdated 6mo agoby Riconpharma LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 7- tagApproval448 co-mentions · 224 sources
- drugTEGRETOL-XR393 co-mentions · 225 sources
- drugTEGRETOL393 co-mentions · 225 sources
- drugCARBAMAZEPINE225 co-mentions · 225 sources
- drugcarbamazepine Teva225 co-mentions · 225 sources
- tagSmall Molecule224 co-mentions · 224 sources
- tagRecall1 co-mentions · 1 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 7 approved and 9 investigational indications.
indications
investigational
Epilepsy
all catalysts(100)
approval · 100
Mar 11, 1968
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1974
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 20, 1974
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 29, 1974
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 29, 1974
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 29, 1974
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 29, 1974
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 29, 1974
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 29, 1974
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 29, 1974
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Nov 8, 1974
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Nov 15, 1974
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Dec 12, 1974
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 28, 1975
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 31, 1975
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 2, 1975
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Dec 9, 1975
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Dec 12, 1975
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Nov 8, 1976
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Apr 4, 1977
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Apr 4, 1977
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Apr 4, 1977
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 9, 1978
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 9, 1978
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Nov 22, 1978
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Nov 22, 1978
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Apr 9, 1979
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Feb 1, 1980
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 25, 1980
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Dec 8, 1981
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Feb 9, 1982
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 8, 1982
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Sep 14, 1983
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 31, 1984
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 8, 1985
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
May 6, 1985
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jan 10, 1986
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jan 10, 1986
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Feb 3, 1986
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jun 2, 1986
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 31, 1987
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 31, 1987
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Dec 18, 1987
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 28, 1988
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 28, 1988
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 1, 1988
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 1, 1988
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 8, 1988
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Apr 7, 1989
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Apr 7, 1989
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 21, 1989
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 21, 1989
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 1, 1989
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 26, 1990
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 26, 1990
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 27, 1990
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 28, 1990
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 28, 1990
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jun 1, 1990
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 14, 1991
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 14, 1991
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Oct 6, 1993
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Oct 6, 1993
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 9, 1995
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Oct 5, 1995
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Oct 11, 1995
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Oct 11, 1995
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 25, 1996
approval
$NVS160.20-0.19%
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jun 24, 1996
approval
$NVS160.20-0.19%
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 26, 1996
approval
$NVS160.20-0.19%
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Sep 24, 1996
approval
$NVS160.20-0.19%
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jan 2, 1997
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 6, 1997
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1998
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1998
approval
$NVS160.20-0.19%
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1998
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1998
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1998
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1998
approval
$NVS160.20-0.19%
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1998
approval
$NVS160.20-0.19%
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1998
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1998
approval
$NVS160.20-0.19%
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1998
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1998
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jul 15, 1998
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Sep 17, 1998
approval
$NVS160.20-0.19%
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Dec 29, 1998
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jan 4, 1999
approval
$NVS160.20-0.19%
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Feb 19, 1999
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Apr 21, 1999
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Apr 22, 1999
approval
$NVS160.20-0.19%
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jun 7, 1999
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jun 29, 1999
approval
$NVS160.20-0.19%
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Feb 14, 2000
approval
$NVS160.20-0.19%
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 7, 2000
approval
$NVS160.20-0.19%
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Mar 8, 2000
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Apr 10, 2000
approval
$NVS160.20-0.19%
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Apr 10, 2000
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Apr 10, 2000
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Apr 10, 2000
approval
$NVS160.20-0.19%
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Trials studying carbamazepine ER
- phase1A Trial of Lu AH69593 in Healthy Participants
- phase1A Study to Learn How Fluconazole, Carbamazepine and Itraconazole Affect How the Body Processes ASP3082 in Healthy Adults
- phase1A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participants
- phase1A Study to Evaluate the Effect of Food on the Single-Dose Pharmacokinetics and a Drug-Drug Interaction Evaluation of Itraconazole and Carbamazepine on INCB123667 When Administered Orally to Healthy Adult Participants
- phase1A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together
- phase1Drug-drug Interaction Trial of AP31969 and Carbamazepine or Itraconazole
- phase1A Study to Test the Effects of Itraconazole and Carbamazepine on OPC-167832 in Healthy Men and Women
- phase1A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144
Patent cliff
source: FDA Orange Bookfirst barrier falls
Nov 10, 2028
~2.0 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (7)
- Jan 31, 2040formulationUS 11529357
- Feb 27, 2033formulationUS 9493582
- Mar 13, 2029formulationUS 76357732.3y
- Mar 13, 2029formulationUS 84100772.3y
- Mar 13, 2029formulationUS 97508222.3y
- Nov 10, 2028method-of-use (U-2006)US 96297972.0y
- Nov 10, 2028formulationUS 97704072.0y
News(1)
- FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High RiskFDA today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a rec…fda_press · 7d ago
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that